FDA Inspection
Merck Sharp & Dohme LLCMerck Sharp & Dohme LLC – FDA Inspection, Feb 12, 2009
Record Details
This FDA Inspection record concerns Merck Sharp & Dohme LLC, with an inspection on February 12, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Merck Sharp & Dohme LLC
- Inspection Date
- February 12, 2009
- Product Type
- Biologics
View Company Profile
ID · 3b7b84dd-5f1d-4639-bc7e-0fe14847d807
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 565350
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of Merck Sharp & Dohme LLC
15| Date | Classification | Office | Project area |
|---|---|---|---|
| July 15, 2025 | Not classified | Philadelphia District Office | |
| December 12, 2024 | Not classified | Philadelphia District Office | |
| August 23, 2024 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| July 27, 2021 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| September 20, 2019 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Merck Sharp & Dohme LLC
- FDA Inspection 1275520 - 2025-07-15
- FDA Inspection 1252348 - 2024-12-12
- FDA Inspection 1229927 - 2024-08-23
- FDA Inspection 1155052 - 2021-07-27
- FDA Inspection 1103540 - 2019-09-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.